Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 4.75M | $ 802.84K | $ 1.8M | $ 2.15M |
3/31/2025 | $ 5.55M | $ 444.71K | $ 2.94M | $ 2.17M |
12/31/2024 | $ 6.51M | $ 1.11M | $ 3.23M | $ 2.18M |
9/30/2024 | $ 6.55M | $ 756.58K | $ 3.6M | $ 2.19M |
6/30/2024 | $ 6.66M | $ 801.31K | $ 3.65M | $ 2.21M |
3/31/2024 | $ 8.05M | $ 2.45M | $ 3.37M | $ 2.22M |
12/31/2023 | $ 8.22M | $ 2.82M | $ 3.16M | $ 2.24M |
9/30/2023 | $ 10.19M | $ 4.51M | $ 3.68M | $ 2M |
6/30/2023 | $ 8.87M | $ 8.28M | $ 594.32K | $ 0 |
3/31/2023 | $ 10.46M | $ 9.77M | $ 695.48K | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: Assets [ $ 1.45M ] - Intangibles [ $ 0 ] - CashnEq [ $ 1.36M ]
(=) Core Assets [ $ 92.67K ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 803.6M |
median | $ 289.12M |
std | $ 1.06B |